POD24 AND CR30 ARE PROMISING SURROGATE ENDPOINTS FOR...

Hematological Oncology 2017 / 06 Vol. 35

POD24 AND CR30 ARE PROMISING SURROGATE ENDPOINTS FOR ASSESSING THE OUTCOME OF PATIENTS WITH ADVANCED STAGE FOLLICULAR LYMPHOMA ENROLLED IN THE FOLL05 TRIAL BY FIL.

Luminari, S., Marcheselli, L., Manni, M., Anastasia, A., Vitolo, U., Chiarenza, A., Rigacci, L., Angelucci, E., Fama, A., Pulsoni, A., Rattotti, S., Angrilli, F., Gaidano, G., Stelitano, C., Bertolder
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2438_91
Date:
June, 2017
File:
PDF, 219 KB
english, 2017
Conversion to is in progress
Conversion to is failed